Observational studyEuropean radiology2026
Deep learning-based automated contrast enema analysis to improve the assessment of Hirschsprung disease.
Observational study in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo compare the radiologic assessment of Hirschsprung disease (HD) based on contrast enema with automated image analysis using a deep neural network (DNN) for image recognition. MATERIALS AND
methodsA retrospective observational single-centre study was conducted at a tertiary care hospital, including paediatric patients who underwent contrast enema between January 2011 and December 2023, either for suspected HD or other clinical indications. A classifier based on a pretrained DNN (DenseNet121) was developed to detect HD in contrast enema images. DNN performance was assessed using balanced accuracy, sensitivity, and the area under the receiver-operating characteristic curve (AUC-ROC) and area under the precision-recall curve (AUC-PR) analyses. Rectal biopsy was the reference standard, with clinical follow-up in cases where a biopsy was not performed. The DNN classification performance was compared to historical expert radiologic assessment.
resultsA total of 278 contrast enemas were performed in 221 patients (64.8% male, 35.2% female), mean age of 4.14 years and a median of 2.65 years. DenseNet121 achieved 75.3% balanced accuracy, 58.5% sensitivity, and 92.1% specificity per individual image, improving to 82.8%, 72.7%, and 93.0%, respectively, at the contrast enema level. The model achieved a similar AUC-ROC compared to expert radiologists in their original reports (0.830 vs 0.804), and the interobserver agreement was moderate (Cohen´s kappa = 0.475).
conclusionThe DNN model demonstrated higher specificity than radiologists in the interpretation of contrast enemas in patients with suspected HD. Moderate interobserver agreement underscores the model's potential value as a tool for diagnostic support and standardisation, particularly in settings where access to experienced specialists may be limited or in borderline cases. KEY POINTS: Question Contrast enema is commonly used to evaluate suspected HD, but its diagnostic accuracy is variable and dependent on the radiologist's expertise. Findings A deep learning model outperformed radiologists in specificity (93.0% vs 79.1%), however, the difference was not statistically significant, and the interobserver agreement was moderate (Cohen´s kappa = 0.475). Clinical relevanceA DNN trained for automated analysis of contrast enema can identify patterns suggestive of HD with performance comparable to conventional radiological assessment, underscoring its value as a tool for diagnostic support in borderline cases or when access to experienced specialists may be limited.
Indexed as
Identifiers
41572045What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.